Residual and recurrent gradients after septal myectomy for hypertrophic cardiomyopathy—mechanisms of obstruction and outcomes of reoperation  by Cho, Yang Hyun et al.
Cho et al Acquired Cardiovascular DiseaseResidual and recurrent gradients after septal myectomy for
hypertrophic cardiomyopathy—mechanisms of obstruction and
outcomes of reoperationYang Hyun Cho, MD, PhD,a,b Eduard Quintana, MD, FETCS,a,c Hartzell V. Schaff, MD,a
Rick A. Nishimura, MD,d Joseph A. Dearani, MD,a Martin D. Abel, MD,e and Steve Ommen, MDdFrom t
Depa
Sung
lona,
Anes
Disclos
Drs Y.H
Read a
Surg
Receive
for pu
Address
Mayo
(E-m
0022-52
Copyrig
http://dx
A
C
DObjective: The aims of the present studywere to identify the mechanisms of residual or recurrent left ventricular
outflow tract obstruction in patients undergoing repeat septal myectomy for hypertrophic cardiomyopathy and to
assess the early and late results of reoperation.
Methods: From January 1980 to June 2012, we performed 52 repeat myectomies in 51 patients.We reviewed the
medical records and preoperative transthoracic echocardiograms to evaluate the adequacy of the previous resec-
tion andmechanism of left ventricular outflow tract obstruction. The complications of previous and repeat myec-
tomy, New York Heart Association class, and survival were analyzed.
Results: The mean interval from previous myectomy to reoperation was 43  51 months. In 6 patients (12%)
residual or recurrent gradients were caused by isolated midventricular obstruction. In the remaining 46 opera-
tions, the mechanism of residual or recurrent gradients was identified as systolic anterior motion of mitral valve-
related subaortic obstruction caused by inadequate length of previous subaortic septal excision in 31 patients
(59% of the total), both an inadequate length and an inadequate depth of septectomy in 13 patients (25%),
and both residual subaortic obstruction due to systolic anterior motion of the mitral valve and midventricular
obstruction in 2 patients (4%). Preoperatively, 96% of patients were in New York Heart Association class III
or IV; postoperatively, 93.8% were in class I or II (P< .001). The 10-year survival after reoperation was
98% and similar to that of an age- and gender-matched Minnesota population (P ¼ .46).
Conclusions: The most common cause of recurrent left ventricular outflow tract obstruction and symptoms in
patients undergoing septal myectomy has been an inadequate length of septal excision. Reoperation is safe, with
excellent long-term survival and functional improvement. (J Thorac Cardiovasc Surg 2014;148:909-16)Fixed or provocable left ventricular (LV) outflow tract
(LVOT) obstruction will be present in as many as 70% of
patients with hypertrophic cardiomyopathy (HCM).1 In
obstructive HCM, LVOT narrowing will be caused by septal
hypertrophy combined with systolic anterior motion of the
mitral valve (SAM); an abnormal papillary muscle can also
contribute to LVOT gradients.2 Patients unresponsive to
medical treatment and with favorable anatomy are good
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improving symptoms and exercise performance.3,4 A
subset of patients undergoing myectomy can have residual
or recurrent obstruction with symptom persistence, and
although the risk of residual gradients is low, little is
known about the mechanisms of recurrent obstruction or
outcomes of reoperation.5 Therefore, the aim of the present
study was to investigate the anatomic abnormalities leading
to reoperation for myectomy and to document the early and
late results of reoperation.METHODS
Patient Selection
From January 1980 to June 2012, 2034 patients underwent septal myec-
tomy for obstructive HCM at our clinic. Of these patients, we identified 51
who had undergone 52 operations for residual or recurrent obstruction after
previous surgical septal myectomy. We included only patients who had a
primary diagnosis of HCM and did not include patients who had undergone
myectomy concurrent with planned aortic valve replacement or patients
who had developed SAM after mitral valve repair. The Mayo Clinic Col-
lege of Medicine institutional review board reviewed and approved the pre-
sent clinical study, and all patients agreed to clinical research authorization
before surgery. To capture the data related to this population, we used the
information from our database and electronic medical records. Follow-up
data were obtained from health assessment questionnaires sent to the pa-
tients and families 1, 3, 5, 10, and 15 years postoperatively and wasrdiovascular Surgery c Volume 148, Number 3 909
Abbreviations and Acronyms
HCM ¼ hypertrophic cardiomyopathy
LV ¼ left ventricular
LVOT ¼ LVoutflow tract
SAM ¼ systolic anterior motion of mitral valve
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Dsupplemented by written correspondence from the referral physicians or
the patients themselves; vital status was determined from the Social Secu-
rity Death Index.
All patients had at rest or provoked gradients of50mmHg determined
preoperatively using transthoracic Doppler echocardiography or an inva-
sive hemodynamic study if the outflow tract gradients could not be deter-
mined by Doppler echocardiography. Echocardiographic studies were
performed at baseline according to the recommendations of the American
Society of Echocardiography.3 The LVOT gradients were measured using
continuous-wave Doppler of the outflow tract from an apical window and
calculated using the modified Bernoulli equation (gradient¼ 4v2, v¼ peak
LVOT velocity). If a significant gradient was not obtained under basal con-
ditions, a Valsalva maneuver and/or administration of amyl nitrate or exer-
cise was used to provoke a gradient. If the patients were stable in the
operating room before cardiopulmonary bypass, pressure measurements
were obtained again by directly measuring the intracavitary (LV) and aortic
pressures.6
Of the 52 patients, 32 had undergone their first operation for septal
myectomy elsewhere. The remaining 20 patients had undergone their
initial operation at our institution, representing approximately 1% of pa-
tients undergoing primary myectomy. Two patients had residual obstruc-
tion after 2 previous myectomies, and 3 patients had undergone previous
percutaneous alcohol septal ablation.
Recurrent Obstruction Etiology
The site of recurrent obstruction was identified primarily using a para-
sternal long-axis view. Images of the preoperative echocardiograms and
operative records of all the patients were reviewed by 3 of us (Y.H.C.,
E.Q., and H.V.S.). In each patient, consensus was reached regarding the
morphologic features causing obstruction. The previous myectomy site
was visually evaluated. The presence of SAM was a marker of dynamic
LVOT obstruction, indicating residual or recurrent subaortic obstruction.
A midventricular obstructive pattern was defined when no SAM was pre-
sent and the midventricular septum was responsible for a significant intra-
cavitary gradient. The anatomy of the papillary muscle was also reviewed
as a possible cause of LVOT obstruction. From these findings, we catego-
rized the mechanisms of recurrent obstructions as an insufficient length of
septal excision, an inadequate depth of septal excision, midventricular
obstruction, or obstruction due to an abnormal papillary muscle (Figure 1).
An important goal of the present study was to determine whether late
LVOT obstruction might reflect regrowth of the muscle in the area of pre-
vious myectomy. Thus, we analyzed further those patients from our clinic
who had had marked improvement in their clinical status initially after the
previous myectomy. We then compared the Doppler echocardiograms
obtained early after initial myectomy with the studies obtained before
reoperation to compare the septal anatomy and previous myectomy site.
Surgical Procedure
The operations were performed using standard methods for repeat me-
dian sternotomy, including normothermic cardiopulmonary bypass with
single venous cannula and antegrade cold blood cardioplegia for myocar-
dial protection. Exposure is facilitated by complete lysis of adhesions to
allow the ventricles to collapse and be displaced posteriorly. Next, an ob-
lique aortotomy is made; we have preferred to situate this slightly closer910 The Journal of Thoracic and Cardiovascular Surgto the sinotubular ridge than usual for aortic valve replacement. The aortic
incision is carried through the midpoint of the noncoronary aortic sinus of
Valsalva to a level approximately 1 cm above the valve annulus. The edge
of the proximal aorta is held out of the way with small stay sutures, and a
cardiotomy sucker is placed through the aortic valve and used to depress
the anterior leaflet of the mitral valve to protect it from injury. The right
aortic valve cusp is collapsed against the sinus wall, where it will usually
stay.
The region of residual septal obstruction can be recognized by the endo-
cardial scar resulting from contact with the anterior mitral valve leaflet. The
technique used for relief of residual subaortic obstruction is similar to that
used for primary operations.7 The septum is incised with a no. 10 scalpel
blade just to the right of the nadir of the right aortic sinus. Incision in the
septum should be made upward and then leftward over to the anterior
leaflet of the mitral valve. We use scissors to complete excision of this
initial portion of the myocardium. A sponge stick is used to depress the
right ventricle and to rotate the septum posteriorly, orienting the LVoutflow
anteriorly. The area of septal excision is then deepened and lengthened to-
ward the apex of the heart, being certain to excise the hypertrophied septum
beyond endocardial scar. Next, the myectomy site is further enlarged using
pituitary rongeurs. An adequate septal myectomy will usually yield 3 to 12
g of muscle, and the depth of resection will depend on the thickness of the
septum; however, it will rarely be<10 mm.
If the level of obstruction is distant from the aortic valve, precluding
transaortic access, apical left ventriculotomy should be performed to pro-
vide access to the midventricular septum.8 To confirm complete relief of
the LVOT obstruction, we used intraoperative echocardiography and
routinely measured the simultaneous aortic and LV ventricular pressures
by direct needle puncture before and after myectomy. The patients under-
went the surgical ablative procedure using a transaortic approach (n¼ 45),
transventricular myectomy (n¼ 4), or combined transaortic and transapical
approach (n¼ 3). In addition to surgery to relieve the obstruction caused by
HCM, 19 concomitant procedures were performed in 16 patients (Table 2).
Follow-up and Analysis
Statistical analyses were performed using Statistical Analysis Systems
software, version 9.1 (SAS Institute, Cary, NC). Descriptive statistics for
categorical variables are reported as frequencies and percentages and
continuous variables as the mean  standard deviation. The Kaplan-
Meier method was used to estimate late survival. Observed late survival
was compared using a log-rank test with the expected survival of an age-
and gender-matched Minnesota population. In the analysis of functional
status, we used the most current follow-up information.RESULTS
The mean patient age at repeat myectomy was 38.1 
18.9 years, and 18 patients were men (35%). All patients
had cardiac limitations at reoperation, with symptoms of
left heart failure, dyspnea, and fatigability, despite medical
treatment with 1 or 2 negative inotropic agents (Table 1). In
addition, 11 patients (22%) had angina pectoris, and 7
(14%) had syncope. Formal exercise tests were recorded
for 19 patients, whose functional aerobic capacity was
59%  24% of predicted. Among all the patients, the
symptom-free interval after the previous myectomy was
22  42 months, and repeat myectomy was performed at
a mean of 43  51 months after the previous procedure
(Table 2).
At reoperation, 5 patients had permanent transvenous
pacemakers in place because of complete atrioventricularery c September 2014
FIGURE 1. Three types of recurrence after septal myectomy for hypertrophic obstructive cardiomyopathy with their respective parasternal long-axis echo-
cardiographic views: A, Inadequate length and depth of excision, (B) inadequate length of excision, and (C) midventricular obstruction at the level of the
papillary muscles.
Cho et al Acquired Cardiovascular Disease
A
C
Dblock related to the previous operation. Furthermore, 9 pa-
tients had previous implantable cardioverter defibrillator
implants, 5 as primary prevention and 4 as secondary pre-
vention, after resuscitation from sudden cardiac death.
Dual chamber pacemaker implantations aimed at reducing
the LVOT gradients9 had been performed at different times
before redo myectomy in 9 additional patients.
Before reoperation, 4 subjects were in atrial fibrillation,
and 51 were in sinus rhythm or paced as described in the
previous paragraphs. Among the patients without pace-
makers, the electrocardiograms before repeat myectomy
demonstrated normal conduction in 5 patients, left anterior
fascicular block in 2 patients, and a left bundle branch block
pattern in 44 patients.
The mean peak-to-peak LVOT gradients measured intra-
operatively before repeat myectomy were 54  30 mm Hg
at rest and 85  41 mm Hg after provocation. After redo
myectomy, the maximum (provoked) mean peak-to-peak
systolic gradient had decreased to 13  12 mm Hg.
After redo myectomy, 5 patients required implantableThe Journal of Thoracic and Cacardioverter defibrillator implantation before hospital
dismissal: 2 patients had developed new complete heart
block and 2 patients with previous normal intraventricular
conduction and 1 with left anterior fascicular block conduc-
tion had developed new left bundle branch block.
After surgery, symptom improvement was common. Pre-
operatively, 96% of the patients were in New York Heart
Association class III or IV, and, postoperatively, 93.8%
were in class I or II (P<.001; Figure 2).Surgical Findings and Causes of Recurrent
Obstruction
The pathologic anatomic findings causing obstruction
before reoperation were identified as an inadequate length
of excision in 31 patients (59%), a combination of an inad-
equate length and inadequate depth of the previous myec-
tomy in 13 (25%), a combination of an inadequate length
and midventricular obstruction in 2 (4%), and isolated mid-
ventricular obstruction in 6 patients (12%). One patient hadrdiovascular Surgery c Volume 148, Number 3 911
TABLE 1. Clinical and echocardiographic data from 51 patients
undergoing repeat myectomy for obstructive hypertrophic
cardiomyopathy
Variable Value
Clinical data
Age (y) 38.1  18.9
Male gender 18 (35)
BSA (m2) 1.8  0.4
Hypertension 5 (10)
Chronic atrial fibrillation 4 (8)
History of stroke 4 (8)
NYHA III-IV 49 (96)
Previous percutaneous alcohol septal ablation 3 (6)
Preoperative ICD 9 (18)
Preoperative pacemaker 9 (18)
Patient history of sudden death 4 (8)
Family history of sudden death 7 (14)
Preoperative b-blocker or calcium channel blockers
or both
51 (100)
Preoperative diuretics 17 (33)
Complications from previous myectomy
Iatrogenic VSD 4 (8)
Complete AV block 5 (10)
Aortic valve injury 6 (12)
Procedures combined with previous myectomy
Aortic valve replacement 2 (4)
CABG 3 (6)
Iatrogenic VSD repair 3 (7)
Mitral valve repair 6 (12)
Measurements
LVOT gradient at rest (mm Hg) 54  30
Provoked LVOT gradient (mm Hg) 85  41
LVEF (%) 71.2  7.8
Basal septal thickness (mm) 20.5  7
Posterior wall (mm) 13.3  3.8
LVEDD (mm) 43  6
LVESD (mm) 24  5
LA volume index (mL/m2) 47  16
LV mass index (g/m2) 171  74
Severity of diastolic dysfunction (grade 0-4) 2.4  0.9
Right VSP (mm Hg)/systemic systolic pressure
(mm Hg)
35.4  7.8
Preoperative exercise test (% functional aerobic
capacity predicted per age)*
60  24
Preoperative SAM 46 (88)
Mitral regurgitation (moderate or greater) 37 (73)
Data presented as n (%) or mean  standard deviation. BSA, Body surface area;
NYHA, New York Heart Association; ICD, implantable cardioverter defibrillator;
VSD, ventricular septal defect; AV, atrioventricular; CABG, coronary artery bypass
grafting; LVOT, left ventricular outflow tract; LVEF, left ventricular ejection fraction;
LVEDD, left ventricular end-diastolic diameter; LVESD, left ventricular end-systolic
diameter; LA, left atrial; VSP, ventricular systolic pressure; SAM, systolic anterior mo-
tion of mitral valve; LV, left ventricular. *Data available for 19 patients.
TABLE 2. Intraoperative and postoperative data (n ¼ 51 patients)
Variable Value
Intraoperative data following repeat myectomy
Extracorporeal circulation time (min) 63  37
Aortic occlusion time (min) 45  27
Amount of septal tissue removed (g) 5.4  4.1
SAM (mild or greater) 0
Mitral valve regurgitation greater than mild 0
Residual transventricular gradient (mm Hg) 13  12
Concomitant procedures
Aortic valve repair 1 (2)
CABG 1 (2)
ASD closure 1 (2)
Tricuspid valve repair 2 (4)
Tumor removal 2 (4)
Aortic valve replacement 4 (8)
Mitral valve repair 4 (8)
VSD repair 4 (8)
Related surgical complications
Aortic valve injury 0
New complete atrioventricular block 2 (4)
New iatrogenic VSD 2 (4)
ICU or hospital data
Intubation>24 h 4 (8)
Median ICU stay (d) 1
Median hospital stay (d) 6
Data presented as n (%) or mean standard deviation. SAM, Systolic anterior motion
of mitral valve; CABG, coronary artery bypass grafting; ASD, atrial septal defect;
VSD, ventricular septal defect; ICU, intensive care unit.
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Dabnormal papillary muscles combined with midventricular
obstruction. Of the 11 pediatric patients (aged<18 years)
in the present series, recurrence of obstruction had resulted
from an insufficient length of septectomy in 9 patients and
midventricular obstruction in 2.912 The Journal of Thoracic and Cardiovascular SurgMitral Regurgitation and SAM
Preoperatively, mitral regurgitation was common; how-
ever, the severity varied in relation to the SAM and dynamic
outflow obstruction. If the mitral valve was structurally
normal, mitral regurgitation improved or disappeared after
myectomywithout additional direct procedures on the valve
itself. In 4 patients with intrinsic abnormalities of the mitral
leaflets, direct valve repair was necessary at myectomy.10
No patients required mitral valve replacement.Early and Late Survival
No in-hospital mortality occurred; however, 1 patient
died after hospital dismissal within 30 days after surgery.
The postmortem examination revealed pulmonary embo-
lism. Three late mortalities occurred. One patient with se-
vere pulmonary hypertension died 13 years after surgery
of unclear reasons. Another patient died of cancer 11 years
after surgery, and 1 patient died of unknown causes 10 years
after repeat myectomy. The Kaplan-Meier 10-year survival
rate was 98% and at 15 years was 82%. Survival after
repeat myectomy was similar to that of an age- and
gender-matched Minnesota population (P ¼ .46; Figure 3).
Special attention was given to patients who had had an
initial improvement in symptoms and had undergone their
first operation at our institution. Among these patients, theery c September 2014
FIGURE 2. Change in New York Heart Association functional class after repeat myectomy. Most patients experienced symptom improvement and were in
class I or II (93.8%) at the last follow-up visit.
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Dpostmyectomy intraoperative LVOT gradients at the initial
operation had averaged 9.2  8.2 mm Hg, and the symp-
toms had recurred at an average of 38  24 months afterFIGURE 3. A, Kaplan-Meier survival curve of patients who had under-
gone repeat septal myectomy (solid curve). B, The survival was not inferior
(P¼ .46) to that of an age- and gender-matched population (dashed curve).
The Journal of Thoracic and Cathe initial septal myectomy. Detailed comparisons of the in-
traoperative echocardiograms from the first procedure and
those performed just before redo myectomy showed no ev-
idence of regrowth of the subaortic septum. In 2 pediatric
patients, the recurrence could be attributed to septal muscle
growth at the midventricular level; however, interpretation
of the changes was difficult because of somatic growth.DISCUSSION
Recurrent symptoms after myectomy for obstructive
HCM can be caused by a variety of problems, including
LV diastolic dysfunction, valvular abnormalities, develop-
ment of coronary artery disease, medication-related symp-
toms, arrhythmias, persistence of pulmonary arterial
hypertension, and dynamic or fixed LV obstruction. Little
is known about the actual incidence of recurrent obstruction
after septal myectomy. However, our subgroup of patients
with symptoms and recurrent obstruction severe enough
to require reoperation accounted for 1% of all HCM surgi-
cal practice.
Recognition and management of residual or recurrent
LVOT obstruction has varied considerably, depending on
the quality of clinical assessment and expertise available
for this relatively small group of patients. Previously, we re-
ported the outcomes of surgery in 13 patients who had un-
dergone repeat myectomy at our clinic from 1975 to 2003.
In that report, the primary cause of LVOT obstruction was
identified as limited resection. The results of the present
study have provided more detailed information on the
morphologic aspects of incomplete septal myectomy in a
larger cohort of patients with extended follow-up.rdiovascular Surgery c Volume 148, Number 3 913
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DAssessment of the preoperative echocardiograms and
surgical findings revealed that the primary reason for
incomplete myectomy was not continuing the septal exci-
sion far enough toward the apex during the first operation,
and this was identified in 59% of patients. An additional
25% of patients had had both inadequate length and depth
of the septal excision. Recurrent symptoms due to midven-
tricular obstruction were less common (12%).
Several technical factors can limit exposure of the sub-
aortic area and excision of the septal muscle. Visualization
of the subaortic septum will often be more difficult in obese
patients with thick chest walls and in patients with a greater
anteroposterior diameter of the thorax. Also, exposure can
be poor because of the small ascending aorta diameter
and small aortic valve annulus size. Also important is the
level of obstruction and its distance from the aortotomy.
Despite these difficulties, in almost all patients, the site of
subaortic obstruction can be identified by the presence of
the endocardial scar and the area of apposition with the
anterior mitral valve leaflet during systolic anterior motion
of the structure. It is important that the septal excision be
continued distally toward the apex and past the visible endo-
cardial scar.
Understanding the anatomic basis for recurrent LVOT
obstruction is important to avoid the complications of
myectomy. For example, widening the proximal area of
the septal excision in a clockwise direction will increase
the risk of injury to the atrioventricular conduction pathway
and the development of complete heart block. Also, deep-
ening the region of previous myectomy, because of the
mistaken assumption that this is the site of obstruction,
will invite the development of an iatrogenic ventricular
septal defect.
As a general rule, whenever SAM is present, we have first
approached LVOT obstruction through an aortotomy and
the aortic valve. However, when midventricular obstruction
is present without SAM, we have favored exposure of the
midseptum through an apical ventriculotomy. In the present
study, 7 patients (14%) underwent the transventricular
approach for septal myectomy to completely relieve the
obstruction. It is likely that some of these patients would
have been better served by this approach at their initial oper-
ation. Just as is found with subaortic obstruction, an endo-
cardial scar will be present to guide septal the excision in
patients with midventricular obstruction. The scar has
been caused by contact of the papillary muscles with the
septum. Midventricular obstruction can be readily exposed
through an apical ventriculotomy, and the procedure is safe,
with minimal complications related to incision of the
ventricle.11
The evolution of gradients deserves special comment. A
review of the intraoperative courses of the first myectomy in
those patients from our institution (the patients with initial
improvement) revealed that the intraoperative LVOT914 The Journal of Thoracic and Cardiovascular Surggradients were minimal (mean, 9.2  8.2 mm Hg). This
group had experienced symptom recurrence at 38  24
months after the procedure, and a comparison of the septal
morphology by echocardiography demonstrated that
although the gradients were acceptably low after the initial
myectomy, the patients either had some degree of septal
bulging that persisted or midventricular obstruction that
was not appreciated initially. No evidence from these pa-
tients, for whom a direct comparison of the echocardio-
grams was possible, showed that regrowth of the septal
muscle was responsible for the obstruction. As previously
described, the pediatric population is at increased risk of
recurrent symptoms and the need for reoperation owing to
the limited transaortic access that leads to incomplete resec-
tions.12 It is unclear why these patients had low gradients af-
ter the initial myectomy, and it is possible that these had
been minimized by anesthetic effects6 and/or that the gradi-
ents developed later with global LV remodeling.13 The in-
terval of reappearance of symptoms could have been
influenced by effect of recovery from the heart surgery it-
self, individual expectations, and physician judgment. It is
important, therefore, to measure the intraoperative gradi-
ents accurately and compare these with the intraoperative
Doppler echocardiographic findings. Provocative maneu-
vers should be performed (eg, induction of premature ven-
tricular contractions or administration of isoproterenol) to
confirm the absence of an inducible gradient. If additional
resection is necessary, we will remove more muscle from
the distal septum, rather than thinning further the initial
myectomy site.
This patient population is complex; nevertheless, the
operative mortality for repeat myectomy was very low. Pa-
tient survival and symptomatic improvement were similar
to those of the larger group of patients undergoing primary
myectomy. Indeed, the survival of these patients paralleled
that of a gender- and age-matched population. These results
emphasize the importance of identifying residual obstruc-
tion in patients with persistent symptoms after septal myec-
tomy. These findings also highlight the importance of
complete intraoperative assessment of septal myectomy at
the initial operation.CONCLUSIONS
Reoperation for recurrent obstruction in patients with
obstructive HCM is uncommon and but most often required
because of an incomplete initial myectomy. The most
frequent finding was failure to continue the septal excision
far enough toward the apex of the heart. Midventricular
obstruction can also lead to recurrent symptoms.
The authors would like to acknowledge Zhuo Li for statistical
analysis, Judy Lenoch for data retrieval, Michael King for creation
of surgical illustrations, and Mark Zang for echocardiographic im-
aging support.ery c September 2014
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Dr Nicholas G. Smedira (Cleveland, Ohio). Dr Quintana,
excellent presentation. I would like the guests to know that Dr
Quintana is a Fellow at the Mayo Clinic from Barcelona.
I would like to congratulate you on a great presentation, it was a
well-done report, and I congratulate the surgeons from Mayo
Clinic, who have performed>2000 myectomies with a<1% recur-
rence rate. This shows that in expert hands this operation is very
safe and reliable.
I have 2 questions that are mainly technical. You talk about the
length; you mentioned the depth of the resection specimen. The
question I am often asked and that I was asked on Saturday, is
how do you determine this, how do you determine how far down
you go, especially when you have SAM with midventricular
obstruction? How do you determine the thickness of the resection
specimen? Also, you did not mention in the talk or in the report
about the width of your resection. So, could you give us an idea
of how you make those determinations both by echocardiography
and intraoperatively?
Dr Quintana. Thank you, Dr Smedira, for your comments. I
think both questions can be answered through the same concept.The Journal of Thoracic and CaAs we said, usually a scar lesion is present and that can guide
the resection area. We always study the echocardiogram preoper-
atively and determine the thickness of the intraventricular septum
and that gives us an idea of how much we can resect. Usually it is
not less than 1 cm.
Also, we want to make a point here. Usually when a patient has
just had an inadequate length of excision at the previous operation,
the commonmistake has been to perform the myectomy just below
the aortic valve, which will lead to ventricular septal defect crea-
tion. This emphasizes the need for the myectomy to be continued
down below and toward the LV apex.
In terms of the width, we guide the resection by studying the
scar tissue and having an idea of where the point of obstruction is.
Dr Smedira. In the small number of patients who have had
recurrence of the obstruction, as I understand it, they did not
have a provocable gradient in your hands during the first operation.
Dr Quintana. That is true.
Dr Smedira. Also, you measured the septal thickness, and no
growth was found. So, it does not regrow, but this suggests, indi-
rectly, that too much septum had been left at the first operation.
After seeing that, what would you do differently now to try and
avoid that very small number of patients who had had an inade-
quate resection? Any difference? Are you doing direct pressure
measurements, do you think it was missed on the echocardiogram,
or did you not take enough muscle?
Dr Quintana. This series of patients had undergone intraoper-
ative direct measurements by needles placed on the ascending
aorta and the left ventricle.We are still uncertain why the measure-
ments did not detect these residual gradients after the initial myec-
tomy. There could be several speculations such as that after a pump
run and crossclamp time, eventually the myocardium might be
stunned, or the needles might have been be in the wrong place.
But we are unsure about that.
The conclusion we have made from these findings is that we
must systematically measure the gradients, that is something we
already do, and perhaps pay more attention to any residual signif-
icant septal thickness, reviewed on the echocardiogram at surgery.
Dr Daniel H. Drake (Traverse City, Mich). Again, I congratu-
late you on a spectacular series.
We plan our myectomies using axial echocardiography. We
determine the length and depth of the resection from a carefully
defined long-axis view, with a goal of leaving a residual septal
thickness of approximately 1 cm. In your opinion, is that
reasonable?
Dr Quintana. That has been described previously in the series
from the Mayo Clinic. At least 1 cm should be left in the septum to
prevent any potential ventricular septal defect creation, even after
surgery.
Dr Drake. Thank you.
Dr Gilles D. Dreyfus (Monte Carlo, Monaco). I want to
congratulate you on your presentation. I am, however, a bit sur-
prised that you hardly mentioned the mitral valve as a major
component of HCM. When you have SAM and a mitral valve
that is regurgitant, in the series I have done, with a number that
is far less than that at theMayo Clinic but still a significant number,
about 20, 25, we have always treated the mitral valve. SAM is
created by a posterior leaflet that is too high and covers the septum
and anterior leaflet. Not only that, but once you have trimmed the
septum through the aortic valve, if you detach the anterior leaflet ofrdiovascular Surgery c Volume 148, Number 3 915
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Dthe mitral valve, you can resect the septum, because you perfectly
align with the septum. Thus, you treat, not only the muscle, but
also the mitral valve by extending the anterior leaflet and pushing
the coaptation point backward, away from the septum.
So I am a bit surprised, because, really, if I wanted to be a bit
provocative, I would say that HCM is nearly a mitral valve disease
and hardly a muscle disease, and you are treating this just through
the muscle. So would you comment, please, on that. Thank you.
Dr Quintana. Thank you for your comments. I am happy that
you brought up this point. This is an important concept, and it is
usually mentioned.
We see the issue the other way around. We think that the mitral
valve regurgitation is a problem secondary to septal hypertrophy.
We have not seen problems with mitral regurgitation due to
SAM after resecting the hypertrophic septum that was causing
the obstruction. So, usually if myectomy is appropriate, the mitral
valve regurgitation will resolve, except if intrinsic mitral valve dis-
ease is present, such as degenerative disease or whatever. However,
if the mitral valve is structurally normal, nothing needs to be done
on the mitral valve, just an appropriate myectomy.
DrMarc Ruel (Ottawa, Ontario, Canada).One more comment
and question about refractory SAM. What has worked well in our
hands has been to use an edge-to-edge repair, or an Alfieri stitch, if
you will, with excellent results.
Returning to your series, 88% of patients had SAM. In some
cases, the diseasewas more than just hypertrophy but also included916 The Journal of Thoracic and Cardiovascular Surgdistortion of the left ventricle and the relationship of the
mitral valve to the septum. Did you use the Alfieri repair in your
series?
DrQuintana. Thank you very much. None of these patients had
undergone an Alfieri procedure. Only 4 patients underwent mitral
valve repair for intrinsic mitral valve disease, and that was resec-
tion of prolapsing segments and, eventually, a protective
annuloplasty.
Dr Leonard N. Girardi (New York, NY). Dr Quintana, I have 1
question. If you consider the 20 patients from Mayo, it was about
3.5 years from the first operation to the second. If you review their
initial echocardiograms coming out of the operating room, what
sort of LVOT gradients and how much mitral regurgitation did
they have coming out of the operating room after their first opera-
tion? Howmuch should we tolerate before we reclamp, go back in,
and do something else about the mitral valve, as was just
mentioned, or should we do some more resection?
Dr Quintana. Thank you for your question. These patients did
not have systolic anterior motion detected just after myectomy in
the operating room nor a gradient detected by direct needle place-
ment. Thus, we still do not quite understand why we were not able
to detect these persistent gradients. We have not seen muscle re-
growth, but I think if any significant systolic anterior motion and
associated mitral regurgitation is present, anything, probably,
more than mild mitral regurgitation in the context of SAM, it
should probably be reassessed surgically.ery c September 2014
